SNP name | Chromosomal location | Gene | Allele | Effect | p value | Associated trait | Sample | Method/study | References |
---|---|---|---|---|---|---|---|---|---|
rs324650 | 7q33 | CHRM2 | T > A |  | PIQ-6.0 VIQ-1.8 FSIQ-4.0 | Alcohol dependence and major depression | 667 |  | [72] |
rs10457441 | 6q16.1 | MIR2113 | T > A T > C T > G | Decline in episodic memory | < 0.02 |  | 1570 | GWAS | [73] |
rs17522122 | 14q12 | AKAP6 | G > T | Worse performance in episodic memory Working memory Vocabulary and perceptual speed | 4 × 10–9 |  | 1570 | GWAS | [73] |
rs363039 | 20p12.2 | SNAP25 | G > A G > C G > T | Highly associated with IQ variations | < 0.01 |  | 762 |  | [72] |
rs2721173 | 8q24.3 | LRRC14 | C > T |  | 9 × 10–6 |  | 106,736/24,189 |  | [74] |
rs11584700 | 1q32.1 | Near gene LRRN2 | A/G |  | 2.1 × 10–9 |  | 101,069 | GWAS | [74] |
rs7923609 | 10q21.3 | JMJD1C, MIR1296 | A > G |  | 1 × 10–6 |  | 106,736/24,189 |  | [74] |
rs4851266 | 2q11.2 | AFF3, LINCO1104 | C > T |  | 5 × 10–11 |  | 26 population | GWAS | [75] |
rs17518584 | 3p12.1 | CADM2 | C > T C > A | Processing speed | 0.013 | T2D | 944 | GWAS | [76] |
rs1487441 | 6q16.1 | LOC101927335 AL589740.1 | G > A |  | 2 × 10–9 |  | 106,736/24,189 |  | [74] |
rs3213207 | 6 | DTNBP1 | A/G | Â | 0.109 | Â | Â | Single base primer extension | [77] |
rs2350780 | 7q33 | CHRM2 | G > A | Involved in neuronal excitability, synaptic plasticity and feedback regulation of acetylcholine release and performance IQ (PIQ) | 0.016 |  | 371, 391 |  | [78] |
rs35753505 | 8p12 | NRG1 | T > A T > C T > G | Increased performance in cognitive domains and IQ |  |  | 218 |  | [79] |
rs821616 | 1q42.2 | DISC1 | A > T |  |  | Schizophrenia and bipolar disorder | 425 |  | [80] |
rs1800497 | 11q23.2 | ANKK1 | G > A | Insight problem solving | 0.033 |  | 425 |  | [81] |
rs174575 | 11q12.2 | FADS2 | C > G |  | 0.018 |  | 1037 |  | [29] |
rs1535 | 11q12.2 | FADS2 | A > G A > T | Decline ability to elongate and desaturate fatty acid |  | BMI | 1037 |  | |
rs17070145 | 5q34 | WWC1 | C > G/C > T | Associated with episodic memory performance | 0.001 | Alzheimer’s disease | N = 8909, N = 4696 |  | [82] |
rs6439886 | 3q23 | CLSTN2 | A > G | Increased memory performance |  | Alzheimer’s disease cognitive impairment |  | GWAS | [83] |
rs363043 | 20p12 | SNAP-25 | C > T | Increased IQ | < 0.01 |  | Children-371 Adult-391 |  | [84] |
rs363016 | 20p12 | SNAP-25 | C > T | Increased IQ | 0.0001 |  | Children-371 Adult-391 |  | [84] |
rs6265 | 11p14.1 | BDNF, BDNF-AS | C > T | short-term learning |  | Obesity Hypertension |  | GWAS | [85] |
rs2619539 | 6p22.3 | DTNBP1 | C > A C > G |  |  | Schizophrenia | 235 |  | [86] |
rs362602 | 20p12-p11.2 | SNAP-25 | A > G | Increased verbal IQ (VIQ) | 0.005 |  | 232 793 |  | [87] |
rs3758391 | 10q21.3 | SIRT1 | T > C |  |  | Cardiovascular disease diabetes | 682, 563 |  | [88] |
rs11809911 | 1q23.3 | LMXA1 | Â | Associated with reduced IQ and memory/learning | Â | Â | 218 | Â | [79] |
rs9320913 | 6q16.1 | LOCI100129158 AL589740.1 | C > A |  | 4.2 × 10–9 |  | 101,069 | GWAS | [89] |
rs6948054 | 7q31-35 | CHRM2 | A > G A > C | PIQ | 0.041 |  | 2158 |  | [78] |
rs8191992 | 7q31-35 | CHRM2 | A > T |  | 0.036 |  | 2158 |  | [78] |
rs2619528 | 6 | DTNBP1 | C > T | Logical memory immediate Symbol search Random letters decrease performance | 0.098 |  | 1054, 1806, 745 |  | [77] |
rs760761 | 6p22.3 | DTNBP1 | G > A | VIQ, full scale IQ (FSIQ) | 0.026 |  | 108 |  | [77] |
rs324640 | 7q31-35 | CHRM2 | G > A G > T |  | PIQ-5.2 VIQ-1.2 FSIQ-2.9 |  | 667 |  | [72] |
rs2619522 | 6 | DTNBP1 | A > C | Minor allele-lower cognitive ability | < 0.01 | Schizophrenia | 7,592 |  | [90] |
rs2061174 | 7q31-35 | CHRM2 | G > C G > A | Strongly associated with intelligence | < 0.01 |  | 371/391 |  | [91] |
rs17800861 | 16p13.2 | GRIN2A | T > A |  | 2.98 × 10–7 |  | 2,421 |  | [92] |
rs10119 | 19q13.32 | TOMM40 | G > A | Associated with general fluid cognitive function | 5.67 × 10–9 |  | 539,490 |  | [93] |
rs4680 | 22q11.21 | COMT | G > A | Transfers methyl group to catecholamine, to inactivate | < 0.01 | Weight gain/decreased SBP | 165/6969 |  | |
rs4962322 | 10q26.2 | ADAM12 | C > A C > G C > T | Gene family PLEXIN member are mutated | 8 × 10–9 |  | 1238 | GWAS | [94] |
rs10794073 | 10q26.2 | ADAM12 | A > C A > G A > T |  | 2.02 × 10–8 |  | 1238 | GWAS | [94] |
rs1799990 | 20p13 | PRNP | A > G | Associated with a decrease in spatial span, letter number sequencing and matrix reasoning scores | ≤ 0.05 |  | 1091 |  | [95] |
rs1276529 | 6q21 | RFPL4B | G/A/C/T | VIQ | 1 × 10–6 |  | 2421 | GWAS | [92] |
rs1706066 | 6 | RFPL4B |  | VIQ | 7.13 × 10–7 |  | 2421 | GWAS | [92] |
rs1276583 | 6 | RFPL4B |  | VIQ | 1.42 × 10–6 |  | 2421 | GWAS | [92] |
rs12552228 | 9 | TEK |  | Functional IQ(FIQ)/PIQ | 8.51 × 10–7/PIQ-3.8 × 10–6 |  | 2421 | GWAS | [92] |
rs12554799 | 9 | TEK |  | FIQ/PIQ | 8.51 × 10–7/PIQ-3.8 × 10–6 |  | 2421 | GWAS | [92] |
rs705670 | 9q34.3 | LINCO1502 | C > G C > T | PIQ | 3.09 × 10–7 |  | 2421 | GWAS | [92] |
rs4962520 | 10q26.2 | ADAM12 | C > T |  | 1.2 × 10–8 |  | 1238 | GWAS | [94] |
rs2490272 | 6q21 | FOX 03 | C/A/G/T | Positive effect | 9.96 × 10–14 | Associated with human longevity | 78,307 | GWAS | [69] |
rs10236197 | 7p14.3 | PDE1C | T/A/C/G | Showed positive effect | 1.03 × 10–10 |  | 78,307 | GWAS | [69] |
rs2251499 | 13q33.2 | intergenic | T/A/C/G | Showed positive effect | 2.74 × 10–10 |  | 78,307 | GWAS | [69] |
rs66495454 | 1p31.1 | NEGR1 | TCC/TCCT |  | 9.08 × 10–9 | Diet measurement | 54,119 | GWAS | [69] |
rs113315451 | 20q13.13 | CSE1L Intron variant |  |  | 1.15 × 10–8 |  | 54,119 | GWAS | [69] |
rs236330 | 1 | FNBP1L | C > T | Associated with IQ in adult and children | 3.9  ×10–15 |  | 17 989 |  | [68] |
rs1011313 | 6 | DTNBP1 | T > A/ T > C | Working memory, executive function, freedom from distractibility | < 0.05 |  | 1054 Scottish, 1806 Australian and 745 English |  | [70] |
rs16954078 | 17q21.32 | SKAP1 Intron variant | T/A | Negative effect on IQ | 2.84 × 10–8 |  | 65,866 | GWAS | [69] |
rs411280 | 11q25 | NTM | T > A T > C | FSIQ | < 10–3  |  | 292 nuclear family | GWAS | [71] |
rs3846329 | 4q31.23 | NR3C2 | G > C G > T | FSIQ | < 10–3 |  | 292 nuclear family | GWAS | [71] |
rs363050 | 20p12.2 | SNAP25 | G > A | VIQ | < 0.01 |  | Children-371 Adult-391 |  | [84] |
rs13107325 | 4q24 | SLC39A8 | C > A C > T | High blood Mn causes lower performance for certain IQ subtests, increased sway and increased scores for behavioral problems | < 0.001 |  | 686 |  | [96] |